As KDM5A was previously shown to interlink mitochondrial dysfunction with failure of myogenic differentiation and several predicted key regulators and processes found in this study, it is clearly a candidate master upstream regulator of IBM pathological processes [29]. Here, KDM5A is linked to inclusion body myositis.